BCB Bancorp Inc (NASDAQ: BCBP) has reported earnings for its second fiscal quarter (ending June 30) of $0.14 versus $0.50 for the same period a year ago — a decline of -72%. This result fell […]
Virginia National Bankshares Cor (NASDAQ: VABK) has reported earnings for its second fiscal quarter (ending June 30) of $0.77 versus $1.05 for the same period a year ago — a decline of -27%. E.P.S. were […]
For its second fiscal quarter (ending June 30), Republic Bancorp Inc (NASDAQ: RBCAA) has reported a 21% increase in E.P.S. from $1.06 a year ago to $1.28 in the current quarter. However, this performance was […]
Huntington Bancshares Inc (NASDAQ: HBAN) has reported E.P.S. of $0.30 for its second fiscal quarter (ending June 30) versus $0.36 for the same period a year ago — a decline of -17%. However, this performance […]
Fifth Third Bancorp (NASDAQ: FITB) has reported E.P.S. of $0.82 for its second fiscal quarter (ending June 30) versus $0.82 for the same period a year ago — flat performance. Relative to the consensus estimate […]
Delcath Systems Inc (NASDAQ: DCTH) stock enjoyed a major increase of 10.8% on 7/19/24. The shares closed at $8.23. Moreover, above average trading volume at 129% of normal accompanied the advance. The stock has risen […]
Avid Bioservices Inc (NASDAQ: CDMO) has benefited from exceptional positive changes in investment behavior: its shorter term price trend turned up, and its longer term price trend turned up. Recent meaningful positive changes in fundamentals […]
Ames National Corp (NASDAQ: ATLO) has reported E.P.S. of $0.24 for its second fiscal quarter (ending June 30) versus $0.28 for the same period a year ago — a decline of -14%. For the latest […]
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $8.17 on 7/19/24 after a major decline of -13.8%. Moreover, this decline was accompanied by above average trading volume at 134% of normal. The stock has risen […]
XBiotech Inc (NASDAQ: XBIT) stock suffered a major decline of -10.9% on 7/19/24. The shares closed at $5.97. This decline was accompanied by normal trading volume. The stock has declined -10.4% during the last week […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research